Skip to main content
Top
Published in: Diabetologia 8/2014

01-08-2014 | Article

Intensified insulin treatment is associated with improvement in skin microcirculation and ischaemic foot ulcer in patients with type 1 diabetes mellitus: a long-term follow-up study

Authors: Björn Rathsman, Kerstin Jensen-Urstad, Thomas Nyström

Published in: Diabetologia | Issue 8/2014

Login to get access

Abstract

Aims/hypothesis

We investigated skin microcirculation and its association with HbA1c and the incidence of ischaemic foot ulcer in patients with type 1 diabetes formerly randomised (1982–1984) to intensified conventional treatment (ICT) or standard treatment (ST) with insulin for a mean of 7.5 years.

Methods

We re-determined the skin microcirculation of 72 patients (ICT 35 vs ST 37) from the original Stockholm Diabetes Intervention Study with iontophoresis topically applied with the following vasoactive stimuli: acetylcholine (ACh) (endothelial-dependent vasodilatation), sodium nitroprusside (SNP) (endothelial-independent vasodilatation), and capsaicin (C-nociceptive-dependent vasodilatation). HbA1c levels (mean of 14 values/patient) were prospectively collected between 1990 and 1995 and tested for association with skin microcirculation. The patients were followed until first hospitalisation for an ischaemic foot ulcer or until 2011.

Results

During the median 28 years of follow-up, three patients developed ischaemic foot ulcers in the ICT group compared with ten in the ST group (logrank, p = 0.035). At the time of iontophoresis, HbA1c was lower in the ICT group (median 57 mmol/mol [minimum–maximum 40–79 mmol/mol]) compared with the ST group (68 mmol/mol [41–96 mmol/mol], p < 0.01) (DCCT: ICT 7.4% [5.8–9.4%] vs ST 8.4% [5.9–10.9%]). Stimulated blood flow was higher in the ICT vs ST group with significantly increased perfusion units (PU) for: ACh (8.1 PU [4.6–24.7 PU] vs 5.3 PU [1.7–21.4 PU], p < 0.01); SNP (8.1 PU [2.2–20.1 PU] vs 5.6 PU [2.3–19.2 PU], p = 0.03); and capsaicin (5.0 PU [1.7–22.9 PU] vs 3.4 PU [1.5–8.4 PU], p < 0.01). HbA1c was associated with vasodilatation induced by ACh (b = −0.02, p < 0.01) and capsaicin (b = −0.02, p = 0.03). HbA1c was independently associated with ACh (b = −1.48, p < 0.01) and capsaicin-induced vasodilatation (b = −1.45, p < 0.01).

Conclusions/interpretation

Improved glycaemic control in patients with type 1 diabetes is associated with an improvement in skin microcirculation and with a lower incidence of ischaemic foot ulcers.
Trial registration: ClinicalTrials.gov NCT01957930
Literature
1.
go back to reference Boulton AJ, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J (2005) The global burden of diabetic foot disease. Lancet 366:1719–1724PubMedCrossRef Boulton AJ, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J (2005) The global burden of diabetic foot disease. Lancet 366:1719–1724PubMedCrossRef
2.
go back to reference Lehto S, Ronnemaa T, Pyorala K, Laakso M (1996) Risk factors predicting lower extremity amputations in patients with NIDDM. Diabetes Care 19:607–612PubMedCrossRef Lehto S, Ronnemaa T, Pyorala K, Laakso M (1996) Risk factors predicting lower extremity amputations in patients with NIDDM. Diabetes Care 19:607–612PubMedCrossRef
3.
go back to reference Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414:813–820PubMedCrossRef Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414:813–820PubMedCrossRef
4.
go back to reference Feihl F, Liaudet L, Waeber B, Levy BI (2006) Hypertension: a disease of the microcirculation? Hypertension 48:1012–1017PubMedCrossRef Feihl F, Liaudet L, Waeber B, Levy BI (2006) Hypertension: a disease of the microcirculation? Hypertension 48:1012–1017PubMedCrossRef
5.
go back to reference Boulton AJ (2004) The diabetic foot: from art to science. The 18th Camillo Golgi lecture. Diabetologia 47:1343–1353PubMedCrossRef Boulton AJ (2004) The diabetic foot: from art to science. The 18th Camillo Golgi lecture. Diabetologia 47:1343–1353PubMedCrossRef
6.
go back to reference Veves A, Akbari CM, Primavera J et al (1998) Endothelial dysfunction and the expression of endothelial nitric oxide synthetase in diabetic neuropathy, vascular disease, and foot ulceration. Diabetes 47:457–463PubMedCrossRef Veves A, Akbari CM, Primavera J et al (1998) Endothelial dysfunction and the expression of endothelial nitric oxide synthetase in diabetic neuropathy, vascular disease, and foot ulceration. Diabetes 47:457–463PubMedCrossRef
7.
go back to reference (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 329:977-986 (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 329:977-986
8.
go back to reference Reichard P, Nilsson BY, Rosenqvist U (1993) The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 329:304–309PubMedCrossRef Reichard P, Nilsson BY, Rosenqvist U (1993) The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 329:304–309PubMedCrossRef
9.
go back to reference Nathan DM, Cleary PA, Backlund JY et al (2005) Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353:2643–2653PubMedCrossRef Nathan DM, Cleary PA, Backlund JY et al (2005) Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353:2643–2653PubMedCrossRef
10.
go back to reference Cefalu WT (2005) Glycemic control and cardiovascular disease—should we reassess clinical goals? N Engl J Med 353:2707–2709PubMedCrossRef Cefalu WT (2005) Glycemic control and cardiovascular disease—should we reassess clinical goals? N Engl J Med 353:2707–2709PubMedCrossRef
11.
go back to reference Reichard P, Britz A, Cars I, Nilsson BY, Sobocinsky-Olsson B, Rosenqvist U (1988) The Stockholm Diabetes Intervention Study (SDIS): 18 months' results. Acta Med Scand 224:115–122PubMedCrossRef Reichard P, Britz A, Cars I, Nilsson BY, Sobocinsky-Olsson B, Rosenqvist U (1988) The Stockholm Diabetes Intervention Study (SDIS): 18 months' results. Acta Med Scand 224:115–122PubMedCrossRef
12.
go back to reference Gudbjornsdottir S, Cederholm J, Nilsson PM, Eliasson B, Steering Committee of the Swedish National Diabetes R (2003) The National Diabetes Register in Sweden: an implementation of the St. Vincent Declaration for Quality Improvement in Diabetes Care. Diabetes Care 26:1270–1276PubMedCrossRef Gudbjornsdottir S, Cederholm J, Nilsson PM, Eliasson B, Steering Committee of the Swedish National Diabetes R (2003) The National Diabetes Register in Sweden: an implementation of the St. Vincent Declaration for Quality Improvement in Diabetes Care. Diabetes Care 26:1270–1276PubMedCrossRef
13.
14.
go back to reference Ragnarson Tennvall G, Apelqvist J, Eneroth M (2000) The inpatient care of patients with diabetes mellitus and foot ulcers. A validation study of the correspondence between medical records and the Swedish Inpatient Registry with the consequences for cost estimations. J Intern Med 248:397–405PubMedCrossRef Ragnarson Tennvall G, Apelqvist J, Eneroth M (2000) The inpatient care of patients with diabetes mellitus and foot ulcers. A validation study of the correspondence between medical records and the Swedish Inpatient Registry with the consequences for cost estimations. J Intern Med 248:397–405PubMedCrossRef
15.
go back to reference Schaper NC, Andros G, Apelqvist J et al (2012) Diagnosis and treatment of peripheral arterial disease in diabetic patients with a foot ulcer. A progress report of the International Working Group on the Diabetic Foot. Diabetes Metab Res Rev 28(Suppl 1):218–224PubMedCrossRef Schaper NC, Andros G, Apelqvist J et al (2012) Diagnosis and treatment of peripheral arterial disease in diabetic patients with a foot ulcer. A progress report of the International Working Group on the Diabetic Foot. Diabetes Metab Res Rev 28(Suppl 1):218–224PubMedCrossRef
16.
go back to reference Jensen-Urstad KJ, Reichard PG, Rosfors JS, Lindblad LE, Jensen-Urstad MT (1996) Early atherosclerosis is retarded by improved long-term blood glucose control in patients with IDDM. Diabetes 45:1253–1258PubMedCrossRef Jensen-Urstad KJ, Reichard PG, Rosfors JS, Lindblad LE, Jensen-Urstad MT (1996) Early atherosclerosis is retarded by improved long-term blood glucose control in patients with IDDM. Diabetes 45:1253–1258PubMedCrossRef
17.
go back to reference Holman RR, Paul SK, Bethel MA, Neil HA, Matthews DR (2008) Long-term follow-up after tight control of blood pressure in type 2 diabetes. N Engl J Med 359:1565–1576PubMedCrossRef Holman RR, Paul SK, Bethel MA, Neil HA, Matthews DR (2008) Long-term follow-up after tight control of blood pressure in type 2 diabetes. N Engl J Med 359:1565–1576PubMedCrossRef
18.
go back to reference Greenman RL, Panasyuk S, Wang X et al (2005) Early changes in the skin microcirculation and muscle metabolism of the diabetic foot. Lancet 366:1711–1717PubMedCrossRef Greenman RL, Panasyuk S, Wang X et al (2005) Early changes in the skin microcirculation and muscle metabolism of the diabetic foot. Lancet 366:1711–1717PubMedCrossRef
19.
go back to reference Boyko EJ, Ahroni JH, Stensel V, Forsberg RC, Davignon DR, Smith DG (1999) A prospective study of risk factors for diabetic foot ulcer. The Seattle Diabetic Foot Study. Diabetes Care 22:1036–1042PubMedCrossRef Boyko EJ, Ahroni JH, Stensel V, Forsberg RC, Davignon DR, Smith DG (1999) A prospective study of risk factors for diabetic foot ulcer. The Seattle Diabetic Foot Study. Diabetes Care 22:1036–1042PubMedCrossRef
20.
go back to reference Tuomilehto J, Borch-Johnsen K, Molarius A et al (1998) Incidence of cardiovascular disease in Type 1 (insulin-dependent) diabetic subjects with and without diabetic nephropathy in Finland. Diabetologia 41:784–790PubMedCrossRef Tuomilehto J, Borch-Johnsen K, Molarius A et al (1998) Incidence of cardiovascular disease in Type 1 (insulin-dependent) diabetic subjects with and without diabetic nephropathy in Finland. Diabetologia 41:784–790PubMedCrossRef
21.
go back to reference Hamdy O, Abou-Elenin K, LoGerfo FW, Horton ES, Veves A (2001) Contribution of nerve-axon reflex-related vasodilation to the total skin vasodilation in diabetic patients with and without neuropathy. Diabetes Care 24:344–349PubMedCrossRef Hamdy O, Abou-Elenin K, LoGerfo FW, Horton ES, Veves A (2001) Contribution of nerve-axon reflex-related vasodilation to the total skin vasodilation in diabetic patients with and without neuropathy. Diabetes Care 24:344–349PubMedCrossRef
22.
go back to reference Petrofsky JS, McLellan K (2009) Galvanic skin resistance—a marker for endothelial damage in diabetes. Diabetes Technol Ther 11:461–467PubMedCrossRef Petrofsky JS, McLellan K (2009) Galvanic skin resistance—a marker for endothelial damage in diabetes. Diabetes Technol Ther 11:461–467PubMedCrossRef
23.
go back to reference Ramsay JE, Ferrell WR, Greer IA, Sattar N (2002) Factors critical to iontophoretic assessment of vascular reactivity: implications for clinical studies of endothelial dysfunction. J Cardiovasc Pharmacol 39:9–17PubMedCrossRef Ramsay JE, Ferrell WR, Greer IA, Sattar N (2002) Factors critical to iontophoretic assessment of vascular reactivity: implications for clinical studies of endothelial dysfunction. J Cardiovasc Pharmacol 39:9–17PubMedCrossRef
24.
go back to reference Millet C, Roustit M, Blaise S, Cracowski JL (2012) Aging is associated with a diminished axon reflex response to local heating on the gaiter skin area. Microvasc Res 84:356–361PubMedCrossRef Millet C, Roustit M, Blaise S, Cracowski JL (2012) Aging is associated with a diminished axon reflex response to local heating on the gaiter skin area. Microvasc Res 84:356–361PubMedCrossRef
Metadata
Title
Intensified insulin treatment is associated with improvement in skin microcirculation and ischaemic foot ulcer in patients with type 1 diabetes mellitus: a long-term follow-up study
Authors
Björn Rathsman
Kerstin Jensen-Urstad
Thomas Nyström
Publication date
01-08-2014
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 8/2014
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-014-3248-2

Other articles of this Issue 8/2014

Diabetologia 8/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine